Germany
Floy GmbH is gaining momentum as a transformative force in the intersection of healthcare and artificial intelligence. Their slogan, "Maximizing the diagnostic value of routine imaging with artificial intelligence," encapsulates their mission to leverage AI for enhanced medical diagnostics.
In an industry where only 3% of healthcare data is actively used, Floy offers a revolutionary solution with certified AI software that not only scrutinizes radiological scans for their intended purposes but also identifies ancillary, potentially critical findings. This capability empowers radiologists, enabling more comprehensive decision-making that adds tangible value to patient care.
Since its inception in 2021, Floy has swiftly attracted over €12 million in funding and established a robust presence across more than 250 radiology sites in Germany and Europe. Their recent €3.60 million seed investment on 01 February 2025 saw participation from major investors such as Founders Fund, HV Capital, and others.
With its headquarters in Germany, Floy GmbH stands at the forefront of revolutionizing healthcare diagnostics, aiming to maximize human health by integrating cutting-edge technology with medical expertise.
Vara
